News & Study Check
Pantoprazole Recall 2026
Which batches are affected – and what long-term PPI use really means
Veyt™ Nutrition · Evidence-based Guide
TL;DR
On September 9, 2026, a batch recall for Pantoprazole beta 40 mg was issued in Germany. The affected batches are CV250342 (30 tablets) and CV250344 (100 tablets). According to the Drug Commission of the German Pharmacists, a deviation from the valid specification regarding active ingredient release was identified in the specified batches; in addition, some packs were distributed without the required market release by the qualified person. Concurrently, international recalls exist in 2026, including a US recall of a specific Pantoprazole batch due to discoloration. Important: A batch recall does not mean that Pantoprazole as an active ingredient is generally unsafe. The separate question regarding potential long-term risks of proton pump inhibitors (PPIs) is scientifically complex: observational studies and reviews find correlations with Vitamin B12, magnesium, iron, or calcium, among others, while other investigations show no clear differences for individual nutrients. Therefore, those taking Pantoprazole long-term should not stop taking it on their own, but rather review the indication and appropriate duration of therapy with their doctor.
A Pantoprazole recall quickly makes headlines – especially when reports about potential long-term consequences of proton pump inhibitors are circulating at the same time. However, these two topics must be kept separate. A batch recall initially concerns a specific drug batch with a specific quality issue. Conversely, the question of whether long-term treatment with proton pump inhibitors is sensible and what potential side effects or nutrient changes may occur is a separate medical and scientific issue.
Therefore, this article will first show which Pantoprazole batches were recalled in Germany in 2026. Subsequently, we will contextualize international recalls, explain what Pantoprazole does in the body, examine the discussion surrounding Vitamin B12, magnesium, iron, and calcium, and finally compare the perspective of Dr. Eric Berg with scientific evidence.
Which Pantoprazole batches are being recalled in Germany in 2026?
The current German batch recall
On September 9, 2026, a batch recall for Pantoprazole beta 40 mg gastro-resistant tablets was issued in Germany. The manufacturer is betapharm Arzneimittel GmbH. The pack sizes of 30 and 100 tablets are affected.
The published drug information cites a deviation from the valid specification for the active ingredient release parameter as the reason. Additionally, it is noted that isolated packs were distributed without prior market release by the qualified person.
→ Source: Drug Information / AMK Notification, 09/09/2026
| Product | Pack | Batch | Reason |
|---|---|---|---|
| Pantoprazole beta 40 mg | 30 tablets | CV250342 | Deviation in active ingredient release; isolated cases distributed without market release |
| Pantoprazole beta 40 mg | 100 tablets | CV250344 | Deviation in active ingredient release; isolated cases distributed without market release |
As of: September 13, 2026. The recall notice was published on September 9, 2026. Affected pharmacies should check their stock and return existing packs.
What does a deviation in active ingredient release mean?
For gastro-resistant Pantoprazole tablets, the release of the active ingredient is an important quality parameter. Such a test is intended to ensure that the active ingredient is released in the correct manner under the intended conditions.
A deviation from the specification therefore initially means that the product does not meet a defined quality requirement. It does not automatically follow that every dose leads to acute health damage. For consumers, it is crucial whether their own pack actually belongs to the recalled batch.
→ Source: Drug Information / AMK Notification, 09/09/2026
Important for consumers
Check your existing pack for the product name, strength, and batch number. If the data matches a published recall, the next steps should be clarified with your pharmacy or treating practice. A prescribed Pantoprazole should not be stopped independently just because a recall is reported somewhere.
Were there also Pantoprazole recalls outside of Germany in 2026?
Yes. Several quality-related recalls were also published internationally in 2026. In the US, for example, a recall was registered for Pantoprazole Sodium delayed-release tablets 40 mg from the company Hetero or the marketing partner Camber Pharmaceuticals.
Affected there was batch FD253967 with an expiration date of 06/2027. The FDA recall information mentions complaints about tablets that were darker than usual and showed lighter spots. The quantity affected was stated as 4,740 bottles; the recall was classified as Class II.
→ Source: U.S. FDA Recalls Data Sets; supplementary FDA-based recall data: University of Utah Health Pharmacy
Another international case concerns Panto-Denk 40 mg. The Kenyan Pharmacy and Poisons Board published a Class II recall for several batches on July 28, 2026. In long-term stability tests after 24 months at 30 °C and 75% relative humidity, the approved specifications for active ingredient release were not met.
→ Source: Pharmacy and Poisons Board Kenya, Medicine Quality Alert, 28/07/2026
Is Pantoprazole therefore generally dangerous?
Do not conflate recall and long-term risks
No, that conclusion would not be scientifically correct. The current recalls concern specific products or batches and are based on concrete quality deviations. They are not proof that the active ingredient Pantoprazole or all proton pump inhibitors are generally dangerous.
Pantoprazole belongs to the proton pump inhibitors (PPIs). These drugs reduce stomach acid production and are used for conditions such as gastroesophageal reflux disease, certain stomach ulcers, and other acid-related illnesses.
The German health portal describes, for example, that in the case of a stomach ulcer, proton pump inhibitors like Omeprazole or Pantoprazole are often used over a limited period of about four to eight weeks once certain other causes have been excluded.
→ Source: gesund.bund.de – Stomach ulcer: Treatment
What does Pantoprazole do in the body?
Pantoprazole inhibits the so-called proton pump in the parietal cells of the stomach. This results in the production of less hydrochloric acid and an increase in the pH level in the stomach.
Exactly this effect is therapeutically desired when acid is to be reduced. At the same time, it explains why, with long-term and strong acid suppression, questions regarding digestion and nutrient availability are also being investigated.
Can long-term Pantoprazole use affect Vitamin B12 status?
Vitamin B12 is one of the most frequently discussed topics regarding long-term PPI use. Stomach acid plays a role in the release of Vitamin B12 from food proteins. Therefore, it is biologically plausible that long-term acid suppression can affect availability.
The study situation is, however, not definitive. A meta-analysis from 2023 found a statistically increased probability of a Vitamin B12 deficiency in PPI users, but simultaneously emphasized significant differences between the included studies and an overall limited strength of the association.
A more recent systematic review from 2025, however, reached the conclusion that, based on the markers examined during chronic PPI use, no clear difference in Vitamin B12 status could be demonstrated. The authors point to methodological differences and the limited number of high-quality studies.
→ Sources: Systematic Review & Meta-Analysis on Vitamin B12 and PPIs, 2023; Systematic Review & Meta-Analysis on long-term PPI therapy and Vitamin B12, 2025
Magnesium: a potential long-term aspect
Magnesium is also being investigated in connection with proton pump inhibitors. The existing evidence, however, is not as clear as some health articles suggest.
A current systematic review of older people with long-term PPI use found inconsistent results for magnesium: some investigations showed no clear changes, while others showed signs of changes in pharmacokinetics. For Vitamin B12 and calcium, the results were more consistent.
→ Source: Systematic Review of Long-Term Use of Proton Pump Inhibitors in Older Adults, 2025
Focus on nutrients
In reviews on long-term PPI therapy, Vitamin B12, magnesium, calcium, and iron are specifically discussed. However, it does not follow that every person taking Pantoprazole automatically develops a deficiency. Individual diet, illnesses, age, dosage, and other medications also play a role.
What about iron and calcium?
Gastric acid influences the processing and bioavailability of various nutrients. Therefore, PPIs have been studied in connection with iron, calcium, Vitamin B12, and magnesium status, among others.
A systematic review on long-term PPI therapy describes varying results across the individual nutrients, but concludes that the issue can be clinically relevant and that further high-quality research is necessary.
What does Dr. Eric Berg say about Pantoprazole and stomach acid?
The perspective of Dr. Eric Berg differs significantly from the classic explanation that reflux is primarily caused by too much stomach acid. In his posts, Berg argues the thesis that reflux in some people could be related to too little stomach acid.
In a post from April 2025, Berg writes that while acid blockers can reduce heartburn symptoms, they might not address the underlying cause. He also puts forward the thesis that insufficient stomach acid could slow down digestion and thereby promote the backflow of stomach contents.
→ Source: Dr. Eric Berg, Can You Use Apple Cider Vinegar for Acid Reflux?, 09/04/2025
In another article, Berg explains his view on hypochlorhydria (too little stomach acid) and lists the long-term or excessive intake of proton pump inhibitors and antacids as a potential factor for reduced stomach acid production.
→ Source: Dr. Eric Berg, Low Stomach Acid: Warning Signs, Complications, and Remedies
Scientific context
The explanation “reflux due to too little stomach acid” is a position from functional or alternative health communication and should not be equated with a medical consensus. GERD can have various causes. Berg's perspective is therefore interesting for the discussion, but does not replace a gastroenterological diagnosis.
Dr. Berg vs. Scientific Evidence: What Are the Differences?
| Topic | Dr. Berg | Scientific Classification |
|---|---|---|
| Reflux | Can be linked to too little stomach acid | GERD is multifactorial; a simple equivalence to "too little acid" is not the consensus |
| PPI | Symptoms can be suppressed without solving the cause | PPIs are effective medications for clear indications; unnecessary long-term therapy should be reviewed regularly |
| Nutrients | Reduced stomach acid can impair digestion and nutrient absorption | Some associations are described, but results for individual nutrients remain inconsistent |
The table compares Berg's published position with an evidence-based medical classification. It is not an evaluation of his entire body of work.
What do guidelines say about long-term PPI use?
The American Gastroenterological Association (AGA) recommends that people without a definitive indication for chronic PPI therapy consider a controlled trial of discontinuation or de-escalation.
At the same time, there are patient groups for whom long-term PPI therapy may still be appropriate or necessary. These include, for example, certain cases of complicated gastroesophageal reflux disease, Barrett's esophagus, or an increased risk of upper gastrointestinal bleeding.
When discontinuing, symptoms of rebound acid hypersecretion may occur temporarily. Therefore, the decision regarding reduction or discontinuation should be made on an individual basis.
→ Source: AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors, 2022
Should you simply stop taking pantoprazole because of the recall?
Do not stop on your own
No. A recall of a specific batch is no reason to independently stop necessary PPI therapy. Abrupt discontinuation can be problematic, especially in conditions where there is a high risk of bleeding, ulcers, or severe reflux complications.
Those taking pantoprazole long-term can instead check with their doctor to see if the original indication still exists, if the dosage is appropriate, and if a gradual reduction is an option.
What can you discuss with your doctor regarding long-term pantoprazole use?
- Why am I taking pantoprazole? Does the original indication still exist?
- What dosage and duration of intake are actually necessary?
- Are there risk factors for nutrient deficiencies? These can include diet, age, comorbidities, or other medications.
- Is a dose reduction or a controlled discontinuation possible?
- Is there a current batch recall for the specific product?
What does the research say overall?
The state of scientific knowledge cannot be responsibly summarized with a simple "pantoprazole is good" or "pantoprazole is dangerous."
The current best assessment is as follows:
Study Check Conclusion
1. The recalls published in 2026 concern specific batches and specific quality issues – not automatically all pantoprazole products.
2. Long-term PPI use is being scientifically studied for various potential risks, including changes in vitamin B12, calcium, magnesium, and iron levels.
3. The evidence varies in strength depending on the endpoint. Some newer analyses show no clear changes for individual nutrients.
4. Dr. Eric Berg holds a significantly more critical view of acid blockers and emphasizes the importance of low stomach acid in reflux. This explanation should be presented as his perspective and not as the medical consensus.
5. The central question is not just whether a PPI can have side effects, but whether there is still a clear medical indication for treatment for the individual person.
Frequently asked questions about the 2026 pantoprazole recall
Which pantoprazole batches are affected in Germany?
In the German batch recall of Pantoprazol beta 40 mg published on September 9, 2026, batches CV250342 (30 tablets) and CV250344 (100 tablets) are affected.
Why was Pantoprazol beta recalled?
According to the published recall information, a deviation from the valid specification for active ingredient release was identified. Furthermore, some packages were placed on the market without prior market release by the qualified person.
Is every pantoprazole dangerous?
No. A batch recall does not automatically affect all products containing the active ingredient pantoprazole. Additionally, the concrete long-term risks of PPIs must be considered independently of the recall.
Can pantoprazole affect vitamin B12?
There are studies and meta-analyses investigating a link between long-term PPI use and vitamin B12 deficiency. However, the results are not entirely consistent. A blanket statement that every person on pantoprazole develops a B12 deficiency would not be correct.
Can pantoprazole lower magnesium?
Magnesium is one of the nutrients being studied in connection with long-term PPI use. However, the results are inconsistent. Medical assessment may be useful for individual symptoms or risk factors. For those who notice calf cramps at night while on proton pump inhibitors, the guide Calf cramps at night: medications as potential triggers provides an assessment.
What does Dr. Eric Berg say about proton pump inhibitors?
Berg holds the view that reflux could be partly related to too little stomach acid and that acid blockers do not always address the cause of the problem. This position is documented in his own publications, but it does not automatically represent the medical consensus.
Should I stop taking pantoprazole immediately because of the recall?
No. If you are taking prescribed pantoprazole, you should check the package or batch and clarify the further procedure with your pharmacy or doctor. For long-term therapy, the current indication can also be reviewed.
References & Scientific Citations
- Arzneimittelinformationen / Arzneimittelkommission der Deutschen Apotheker (09.09.2026). Batch Recall: Pantoprazol beta 40 mg
- U.S. Food and Drug Administration (FDA). Recalls Data Sets
- University of Utah Health Pharmacy. Drug Withdrawals and Recalls
- Pharmacy and Poisons Board Kenya (28.07.2026). Class II Medicines Recall of Panto-Denk 40 mg
- Dr. Eric Berg (09.04.2025). Can You Use Apple Cider Vinegar for Acid Reflux?
- Dr. Eric Berg (09.04.2025). Low Stomach Acid: Warning Signs, Complications, and Remedies
- Leung et al. (2023). Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis
- Parnham et al. (2025). Association Between Long-Term Proton Pump Inhibitor Therapy and Vitamin B12 Status
- Systematic Review (2025). Long-Term Use of Proton Pump Inhibitors in Older Adults on Polypharmacy
- Proton Pump Inhibitor Review. Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium
- American Gastroenterological Association (AGA). AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors
- gesund.bund.de. Stomach Ulcer: Treatment
